Lynparza Breast Cancer Clinical Experience Investigation

CompletedOBSERVATIONAL
Enrollment

111

Participants

Timeline

Start Date

August 14, 2018

Primary Completion Date

March 24, 2022

Study Completion Date

March 24, 2022

Conditions
Breast Cancer
Trial Locations (31)

D0819C00005

Research Site, Aichi

Research Site, Aomori

Research Site, Chiba

Research Site, Ehime

Research Site, Fukui

Research Site, Fukuoka

Research Site, Gunma

Research Site, Hiroshima

Research Site, Hokkaido

Research Site, Hyōgo

Research Site, Ibaraki

Research Site, Ishikawa

Research Site, Kagawa

Research Site, Kagoshima

Research Site, Kanagawa

Research Site, Kochi

Research Site, Kyoto

Research Site, Miyagi

Research Site, Nagano

Research Site, Nara

Research Site, Okayama

Research Site, Okinawa

Research Site, Osaka

Research Site, Saitama

Research Site, Shiga

Research Site, Shimane

Research Site, Shizuoka

Research Site, Tokyo

Research Site, Toyama

Research Site, Yamagata

Research Site, Yamaguchi

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY